中线外周T细胞淋巴瘤  

Midline peripheral T-cell lymphoma

作　　者：谢永欣[1] 陈钰[2] 后盾 王爱华[2] 沈杨[2] 沈志祥[2] 

机构地区：[1]福建省龙岩市第二医院血液科,福建364000 [2]上海第二医科大学附属瑞金医院血液科,上海200025 [3]广州市中医大学一附院

出　　处：《肿瘤》2002年第6期501-502,共2页Tumor

摘　　要：目的　总结 13例中线外周T细胞淋巴瘤 (MPTL)探讨其特征、治疗及预后。方法　用病理、免疫酶标方法对 13例MPTL进行确诊 ,采用CHOP方案化疗并观察其预后。结果　 8例CR ,2例PR ,其中 2例CR后复发 ,另 3例NR死亡。结论CHOP方案对MPTL有效。血和尿 β2 MG升高和血清LDH升高应视为预后不良因素。Objective To investigate the clinical characteristics, treatment and the prognosis of midline peripheral T cell lymphoma(MPTL).Methods 13 MPTL were diagnosed by pathology and immunophenotypic analysis and treated by CHOP regime chemotherapy.Results CR: 8 cases with 2 cases relapsing, PR 2 cases and NR 3 cases.Conclusion CHOP is effective for MPTL. The elevation of β 2 MG in blood and urine and serum LDH are factors of poor prognosis.

关 键 词：中线外周T细胞淋巴瘤 淋巴瘤 诊断 治疗 预后 

分 类 号：R733.4[医药卫生—肿瘤]